Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lamb

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
BJU International|September 6, 2017
Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancerDennis R Taaffe, Laurien M Buffart, Robert U Newton, et al.
Ecology|August 19, 2010
Nitrogen and phosphorus additions negatively affect tree species diversity in tropical forest regrowth trajectoriesIlyas Siddique, Ima Célia Guimarães Vieira, Susanne Schmidt, et al.
British Journal of Pharmacology|May 22, 2020
Withdrawn: The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigsMariska van den Berg, Susan Nijboer-Brinksma, Sophie Bos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)Danny Rischin, Lester Peters, Richard Fisher, et al.
Respiratory Research|May 23, 2021
RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthmaDavid Lamb, Dorothy De Sousa, Karsten Quast, et al.
Journal of Medical Imaging and Radiation Oncology|April 5, 2013
Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trialRachel Kearvell, Annette Haworth, Martin A Ebert, et al.
Respiratory Research|February 9, 2021
The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigsMariska P M van den Berg, Susan Nijboer-Brinksma, I Sophie T Bos, et al.
Frontiers in Molecular Biosciences|October 15, 2021
Molecular Dissection of Pro-Fibrotic IL11 Signaling in Cardiac and Pulmonary FibroblastsAnissa A Widjaja, Sivakumar Viswanathan, Dong Jinrui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 28, 2008
Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trialAnne Capp, Mario Inostroza-Ponta, Dana Bill, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2005
Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivationDavid Christie, James Denham, Allison Steigler, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
BJU International|September 6, 2017
Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancerDennis R Taaffe, Laurien M Buffart, Robert U Newton, et al.
Ecology|August 19, 2010
Nitrogen and phosphorus additions negatively affect tree species diversity in tropical forest regrowth trajectoriesIlyas Siddique, Ima Célia Guimarães Vieira, Susanne Schmidt, et al.
British Journal of Pharmacology|May 22, 2020
Withdrawn: The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigsMariska van den Berg, Susan Nijboer-Brinksma, Sophie Bos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)Danny Rischin, Lester Peters, Richard Fisher, et al.
Respiratory Research|May 23, 2021
RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthmaDavid Lamb, Dorothy De Sousa, Karsten Quast, et al.
Journal of Medical Imaging and Radiation Oncology|April 5, 2013
Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trialRachel Kearvell, Annette Haworth, Martin A Ebert, et al.
Respiratory Research|February 9, 2021
The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigsMariska P M van den Berg, Susan Nijboer-Brinksma, I Sophie T Bos, et al.
Frontiers in Molecular Biosciences|October 15, 2021
Molecular Dissection of Pro-Fibrotic IL11 Signaling in Cardiac and Pulmonary FibroblastsAnissa A Widjaja, Sivakumar Viswanathan, Dong Jinrui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 28, 2008
Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trialAnne Capp, Mario Inostroza-Ponta, Dana Bill, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2005
Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivationDavid Christie, James Denham, Allison Steigler, et al.
Pageof 5